Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the ‘CROSS-regimen’ in daily practice

BACKGROUND AND OBJECTIVES: Since the first results of the Dutch randomized CROSS-trial, neoadjuvant chemoradiotherapy (CRT) using carboplatin and paclitaxel followed by resection for primary resectable nonmetastatic esophageal cancer (EC) has been implemented as standard curative treatment in the Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloos-v.Balen, Marissa, Portier, Edmée S H, Fiocco, Marta, Hartgrink, Henk H, Langers, Alexandra M J, Neelis, Karen J, Lips, Irene M, Peters, Femke P, Slingerland, Marije
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016892/
https://www.ncbi.nlm.nih.gov/pubmed/34557905
http://dx.doi.org/10.1093/dote/doab068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016892/
https://www.ncbi.nlm.nih.gov/pubmed/34557905
http://dx.doi.org/10.1093/dote/doab068

Ejemplares similares